SHERMAN MARK ANDREW

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
55
Insider Sells Sum
$49.36M

Insider Activity of SHERMAN MARK ANDREW

According to the SEC Form 4 filings, SHERMAN MARK ANDREW, being in a position of

  1. EVP, Gen. Counsel & Secretary at Dolby Laboratories, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 12802 shares for $1.09M,
    over all time since 2012-02-07, has bought 0 shares, and sold 734542 shares for $49.36M.

The largest sale of all time was on 2018-02-07 and amounted to 91045 shares of Dolby Laboratories, Inc. for $5.76M.

Biography of SHERMAN MARK ANDREW

No biography is available at this moment.

2024-05-28SaleDolby Laboratories, Inc.
DLB
EVP, Gen. Counsel & Secretary
2,283
0.0024%
$79.62$181,772-4.47%
2023-12-19SaleDolby Laboratories, Inc.
DLB
EVP, Gen. Counsel & Secretary
1,663
0.0018%
$86.01$143,038-6.33%
2023-12-18SaleDolby Laboratories, Inc.
DLB
EVP, Gen. Counsel & Secretary
8,856
0.0093%
$86.19$763,270-7.03%
2023-07-12SaleDolby Laboratories, Inc.
DLB
EVP, Gen. Counsel & Secretary
21,000
0.0217%
$89.00$1.87M-8.17%
2023-05-08SaleDolby Laboratories, Inc.
DLB
EVP, Gen. Counsel & Secretary
15,000
0.0156%
$83.59$1.25M-0.3%
2023-02-07SaleDolby Laboratories, Inc.
DLB
EVP, Gen. Counsel & Secretary
2,413
0.0025%
$83.65$201,836-0.78%
2023-02-03SaleDolby Laboratories, Inc.
DLB
EVP, Gen. Counsel & Secretary
12,000
0.0123%
$85.00$1.02M-2.6%
2022-12-20SaleDolby Laboratories, Inc.
DLB
EVP, GEN. COUN. & SECRTY
1,638
0.0017%
$68.09$111,531+22.65%
2022-12-19SaleDolby Laboratories, Inc.
DLB
EVP, GEN. COUN. & SECRTY
5,070
0.0054%
$69.84$354,110+21.99%
2022-12-16SaleDolby Laboratories, Inc.
DLB
EVP, GEN. COUN. & SECRTY
2,334
0.0024%
$70.66$164,921+18.12%
2022-02-09SaleDolby Laboratories, Inc.
DLB
EVP, GEN. COUN. & SECRTY
1,798
0.0017%
$77.23$138,860-4.82%
2021-12-20SaleDolby Laboratories, Inc.
DLB
EVP, GEN. COUN. & SECRTY
1,638
0.0016%
$90.69$148,550-16.48%
2021-12-17SaleDolby Laboratories, Inc.
DLB
EVP, GEN. COUN. & SECRTY
1,663
0.0016%
$90.17$149,953-17.57%
2021-03-01SaleDolby Laboratories, Inc.
DLB
EVP, GEN. COUN. & SECRTY
13,000
0.0127%
$100.00$1.3M-4.62%
2021-02-16SaleDolby Laboratories, Inc.
DLB
EVP, GEN. COUN. & SECRTY
13,000
0.0128%
$95.00$1.24M+1.49%
2021-02-05SaleDolby Laboratories, Inc.
DLB
EVP, GEN. COUN. & SECRTY
27,261
0.0269%
$91.59$2.5M+5.69%
2020-12-18SaleDolby Laboratories, Inc.
DLB
EVP, GEN. COUN. & SECRTY
1,638
0.0016%
$91.96$150,630+4.15%
2020-12-16SaleDolby Laboratories, Inc.
DLB
EVP, GEN. COUN. & SECRTY
5,166
0.0051%
$90.87$469,411+6.07%
2020-11-03SaleDolby Laboratories, Inc.
DLB
EVP, GEN. COUN. & SECRTY
25,000
0.0248%
$80.00$2M+20.77%
2020-11-02SaleDolby Laboratories, Inc.
DLB
EVP, GEN. COUN. & SECRTY
25,000
0.0242%
$76.00$1.9M+24.26%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.